Explorar estándares de referencia de sustancias controladas y materiales de investigación.
| Compuesto | N.º CAT | N.º CAS | Categoría | Acción |
|---|---|---|---|---|
| Loprazolam-D8 | CS-O-41674 | - | Stable Isotopes | |
| Lorazepam | CS-T-57075 | 846-49-1 | API | |
| Lorazepam 13C6 | CS-EK-01810 | 846-49-1 unlabeled | Stable Isotopes | |
| Lorazepam 2-O-β-D-Glucuronide | CS-T-93367 | -- | Glucuronide | |
| Lorazepam Acetate | CS-T-31249 | 2848-96-6 | Impurity | |
| Lorazepam amide derivative | CS-O-47286 | - | Metabolite | |
| Lorazepam CIV (J0I304) | CS-EB-01221 | 846-49-1 | USP Standards | |
| Lorazepam CIV(Secondary Standards traceble to USP) | CS-ER-01213 | 846-49-1 | Secondary Standards | |
| Lorazepam d4 | CS-T-93366 | 84344-15-0 | Stable Isotopes | |
| Lorazepam Dimer Impurity | CS-O-54131 | -- | Impurity | |
| Lorazepam EP Impurity C | CS-EN-00001 | 2955-37-5 | Impurity | |
| Lorazepam EP Impurity D | CS-EN-00002 | 54699-91-1 | Impurity | |
| Lorazepam for system suitability CRS | CS-EP-00603 | - | EP Standards | |
| Lorazepam Glucuronide | CS-ED-00093 | 32781-79-6 | Glucuronide | |
| Lorazepam Impurity 6 | CS-ED-00511 | 2894-71-5 | Impurity | |
| LORAZEPAM IMPURITY D (Y0000718) | CS-EG-02980 | 54699-91-1 | Impurity | |
| Lorazepam Related Compound A | CS-EB-03210 | 2848-96-6 | USP Standards | |
| Lorazepam Related Compound A | CS-IP-00092 | 2848-96-6 | IP Standards | |
| Lorazepam Related Compound A(Secondary Standards traceble to USP) | CS-ER-01214 | 2848-96-6 | Secondary Standards | |
| Lorazepam Related Compound B | CS-EB-03211 | 2958-36-3 | USP Standards | |
| Lorazepam Related Compound B | CS-IP-00093 | 2958-36-3 | IP Standards | |
| Lorazepam Related Compound B(Secondary Standards traceble to USP) | CS-ER-01215 | 2958-36-3 | Secondary Standards | |
| Lorazepam Related Compound C | CS-IP-00094 | 93955-15-8 | IP Standards | |
| Lorazepam Related Compound C | CS-T-11370 | 93955-15-8 | Impurity |
El producto ha sido añadido a su cesta de RFQ.
El producto ha sido añadido a su cesta de RFQ.